Showing results (1681-1690 of 3,793) with videos related to
Sort By:
Pageof 380
Oncoimmunology|January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.Oncoimmunology|January 4, 2018
A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancerSpencer D Martin, Darin A Wick, Julie S Nielsen, et al.Oncoimmunology|January 4, 2018
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancerDai Liu, Guangfu Li, Diego M Avella, et al.Oncoimmunology|January 4, 2018
Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated gangliosideS Faraj, M Bahri, S Fougeray, et al.Oncoimmunology|January 4, 2018
The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesotheliomaChristian M Schürch, Stefan Forster, Frido Brühl, et al.Oncoimmunology|January 4, 2018
ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapySeandean Lykke Harwood, Ana Alvarez-Cienfuegos, Natalia Nuñez-Prado, et al.Oncoimmunology|January 4, 2018
Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumorsA Kunert, M Chmielewski, R Wijers, et al.Oncoimmunology|January 4, 2018
CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacyBingyu Li, Lijun Xu, Chenyu Pi, et al.Oncoimmunology|December 20, 2013
Intratumoral mast cells promote the growth of pancreatic cancerYing Ma, Stephen E UllrichOncoimmunology|December 20, 2013
Blockade of PD-1 immunosuppression boosts CAR T-cell therapyLiza B John, Michael H Kershaw, Phillip K DarcyPageof 380